学科与关键词
关键词
Immune checkpoint inhibitorsmet amplificationnon-small cell lung cancer
- Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancerSu, Shan; Lin, Anqi; Luo, Peng; Zou, Jianjun; Huang, Zhihao; Wang, Xiaojun; Zeng, Yunyun; Cen, Wenchang; Zhang, Xianlan; Huang, Huiyi; Hu, Jinxing*; Zhang, Jian*Annals of Translational Medicine, 2021, 9(18): 1475.被引 3
- Tepotinib plus osimertinib for EGFR mutant (EGFRm) NSCLC with MET amplification (METamp) after first-line (1L) osimertinibTan, Daniel Shao-Weng; Kim, Tae Min; Guarneri, Valentina; Voon, Pei Jye; Lim, Boon Khaw; Wislez, Marie; Huang, Cheng; Liam, Chong Kin; Mazieres, Julien; Tho, Lye Mun; Hayashi, Hidetoshi; Nhung, Nguyen; Chia, Puey Ling; De Marinis, Filippo; Le, Xiuning; Karachaliou, Niki; Brutlach, Sabine; Adrian, Svenja; Ellers-Lenz, Barbara; Wu, Yi-LongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- A pool analysis of MET TKI SCC244 in NSCLC patients with MET overexpressionYu, Y.; Dong, W.; Shi, Y.; Wu, R.; Yu, Q.; Ye, F.; Zhou, C.; Dong, X.; Li, X.; Li, Y.; Li, Z.; Pan, Y.; Shen, H.; Wu, D.; Xu, Z.; Wu, J.; Xu, N.; Qin, Y.; Li, J.; Lu, S.ESMO Asia Congress, Singapore, SINGAPORE, 2022-12-02 To 2022-12-04.
